Symbols / MRNA Stock $53.27 +0.74% Moderna, Inc.

Healthcare • Biotechnology • United States • NMS
MRNA (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Mr. Stéphane Bancel M.B.A.
Exch · Country NMS · United States
Market Cap 21.14B
Enterprise Value 17.08B
Income -3.19B
Sales 2.22B
FCF (ttm) -20.00M
Book/sh 21.95
Cash/sh 13.12
Employees 4,700
Insider 10d —
IPO Dec 07, 2018
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -12.80
PEG —
P/S 9.50
P/B 2.43
P/C —
EV/EBITDA -7.43
EV/Sales 7.67
Quick Ratio 2.23
Current Ratio 2.41
Debt/Eq 17.52
LT Debt/Eq —
EPS (ttm) -8.14
EPS next Y -4.16
EPS Growth —
Revenue Growth 260.20%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-07-31
Earnings (prior) 2026-04-30
ROA -13.09%
ROE -36.56%
ROIC —
Gross Margin -69.89%
Oper. Margin -131.10%
Profit Margin -143.55%
Shs Outstand 396.79M
Shs Float 370.09M
Insider Own 7.31%
Instit Own 76.49%
Short Float 17.98%
Short Ratio 10.34
Short Interest 58.31M
52W High 59.55
vs 52W High -10.55%
52W Low 22.28
vs 52W Low 139.09%
Beta 1.06
Impl. Vol. 85.84%
Rel Volume 1.18
Avg Volume 8.18M
Volume 9.66M
Target (mean) $43.37
Tgt Median $45.00
Tgt Low $21.00
Tgt High $69.00
# Analysts 19
Recom Hold
Prev Close $52.88
Price $53.27
Change 0.74%
About

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as intismeran autogene, cancer antigen therapy, t-cell engager, and cell therapy enhancer; and rare disease products, including propionic and methylmalonic acidemia, and cystic fibrosis. It has strategic alliances and collaborations with Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; immatics N.V.; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$43.37
Mean price target
2. Current target
$53.27
Latest analyst target
3. DCF / Fair value
$-0.91
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$53.27
Low
$21.00
High
$69.00
Mean
$43.37

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-04 main UBS Neutral → Neutral $45
2026-05-04 main Goldman Sachs Neutral → Neutral $49
2026-05-04 main Evercore ISI Group In-Line → In-Line $50
2026-05-04 main RBC Capital Sector Perform → Sector Perform $38
2026-04-02 main Barclays Equal-Weight → Equal-Weight $48
2026-02-23 main Piper Sandler Overweight → Overweight $69
2026-02-17 main Goldman Sachs Neutral → Neutral $41
2026-02-17 main RBC Capital Sector Perform → Sector Perform $30
2026-02-17 main Evercore ISI Group In-Line → In-Line $35
2025-12-12 main Morgan Stanley Equal-Weight → Equal-Weight $28
2025-12-12 init Jefferies — → Hold $30
2025-11-21 reit Piper Sandler Overweight → Overweight $63
2025-11-21 main RBC Capital Sector Perform → Sector Perform $25
2025-11-21 main Leerink Partners Underperform → Underperform $18
2025-11-10 main B of A Securities Underperform → Underperform $21
2025-11-07 main Barclays Equal-Weight → Equal-Weight $25
2025-10-23 main UBS Buy → Buy $40
2025-10-23 main JP Morgan Underweight → Underweight $25
2025-10-23 main Citigroup Neutral → Neutral $28
2025-10-20 reit Needham Hold → Hold —
News
RSS: Latest MRNA news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-05-01 HUSSAIN SHAH ABBAS Director — 5,682 $46.63 $264,952
2026-04-30 TALLETT ELIZABETH E Director — 4,058 — —
2026-04-30 RUBENSTEIN DAVID M Director — 8,116 — —
2026-04-30 NADER FRANCOIS E. Director — 12,174 — —
2026-04-30 HORNING SANDRA Director — 16,233 — —
2026-04-30 NABEL ELIZABETH G Director — 16,233 — —
2026-04-30 HUSSAIN SHAH ABBAS Director — 16,233 — —
2026-04-02 MOCK JAMES M Chief Financial Officer — 1,453 — —
2026-03-05 MOCK JAMES M Chief Financial Officer — 11,797 — —
2026-03-05 KLINGER SHANNON THYME Officer — 11,797 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
1,922.00
-39.92%
3,199.00
-52.64%
6,754.00
-64.22%
18,875.00
Operating Revenue
3,304.00
-26.85%
4,517.00
-44.93%
8,203.00
-55.50%
18,435.00
Cost Of Revenue
868.00
-40.71%
1,464.00
-68.80%
4,693.00
-13.35%
5,416.00
Reconciled Cost Of Revenue
868.00
-40.71%
1,464.00
-68.80%
4,693.00
-13.35%
5,416.00
Gross Profit
1,054.00
-39.25%
1,735.00
-15.82%
2,061.00
-84.69%
13,459.00
Operating Expense
4,128.00
-27.32%
5,680.00
-9.84%
6,300.00
+55.98%
4,039.00
Research And Development
3,132.00
-31.06%
4,543.00
-6.23%
4,845.00
+47.04%
3,295.00
Selling General And Administration
1,018.00
-13.29%
1,174.00
-24.21%
1,549.00
+36.84%
1,132.00
Other Operating Expenses
-22.00
+40.54%
-37.00
+60.64%
-94.00
+75.77%
-388.00
Total Expenses
4,996.00
-30.07%
7,144.00
-35.01%
10,993.00
+16.27%
9,455.00
Operating Income
-3,074.00
+22.08%
-3,945.00
+6.94%
-4,239.00
-145.00%
9,420.00
Total Operating Income As Reported
-3,074.00
+22.08%
-3,945.00
+6.94%
-4,239.00
-145.00%
9,420.00
EBITDA
-2,543.00
+25.07%
-3,394.00
+6.19%
-3,618.00
-137.04%
9,768.00
Normalized EBITDA
-2,538.00
+23.97%
-3,338.00
+7.74%
-3,618.00
-137.04%
9,768.00
Reconciled Depreciation
215.00
+13.76%
189.00
-69.57%
621.00
+78.45%
348.00
EBIT
-2,758.00
+23.03%
-3,583.00
+15.48%
-4,239.00
-145.00%
9,420.00
Total Unusual Items
-5.00
+91.07%
-56.00
+22.22%
-72.00
-260.00%
-20.00
Total Unusual Items Excluding Goodwill
-5.00
+91.07%
-56.00
+22.22%
-72.00
-260.00%
-20.00
Net Income
-2,822.00
+20.75%
-3,561.00
+24.46%
-4,714.00
-156.37%
8,362.00
Pretax Income
-2,768.00
+23.26%
-3,607.00
+8.50%
-3,942.00
-141.17%
9,575.00
Net Non Operating Interest Income Expense
304.00
-24.19%
401.00
-4.75%
421.00
+110.50%
200.00
Interest Expense Non Operating
10.00
-58.33%
24.00
-36.84%
38.00
+31.03%
29.00
Net Interest Income
304.00
-24.19%
401.00
-4.75%
421.00
+110.50%
200.00
Interest Expense
10.00
-58.33%
24.00
-36.84%
38.00
+31.03%
29.00
Interest Income Non Operating
314.00
-26.12%
425.00
+0.95%
421.00
+110.50%
200.00
Interest Income
314.00
-26.12%
425.00
+0.95%
421.00
+110.50%
200.00
Other Income Expense
2.00
+103.17%
-63.00
+49.19%
-124.00
-175.56%
-45.00
Other Non Operating Income Expenses
7.00
+200.00%
-7.00
+94.35%
-124.00
-175.56%
-45.00
Gain On Sale Of Security
-5.00
+91.07%
-56.00
+22.22%
-72.00
-260.00%
-20.00
Tax Provision
54.00
+217.39%
-46.00
-105.96%
772.00
-36.36%
1,213.00
Tax Rate For Calcs
0.00
+1546.67%
0.00
-93.93%
0.00
+65.35%
0.00
Tax Effect Of Unusual Items
-1.05
-47.02%
-0.71
0.00
0.00
Net Income Including Noncontrolling Interests
-2,822.00
+20.75%
-3,561.00
+24.46%
-4,714.00
-156.37%
8,362.00
Net Income From Continuing Operation Net Minority Interest
-2,822.00
+20.75%
-3,561.00
+24.46%
-4,714.00
-156.37%
8,362.00
Net Income From Continuing And Discontinued Operation
-2,822.00
+20.75%
-3,561.00
+24.46%
-4,714.00
-156.37%
8,362.00
Net Income Continuous Operations
-2,822.00
+20.75%
-3,561.00
+24.46%
-4,714.00
-156.37%
8,362.00
Normalized Income
-2,818.05
+19.62%
-3,505.71
+25.63%
-4,714.00
-156.37%
8,362.00
Net Income Common Stockholders
-2,822.00
+20.75%
-3,561.00
+24.46%
-4,714.00
-156.37%
8,362.00
Diluted EPS
—
-9.28
+24.74%
-12.33
-161.28%
20.12
Basic EPS
—
-9.28
+24.74%
-12.33
-158.00%
21.26
Basic Average Shares
—
384.00
+0.52%
382.00
-3.05%
394.00
Diluted Average Shares
—
384.00
+0.52%
382.00
-8.17%
416.00
Diluted NI Availto Com Stockholders
-2,822.00
+20.75%
-3,561.00
+24.46%
-4,714.00
-156.37%
8,362.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
12,338.00
-12.76%
14,142.00
-23.25%
18,426.00
-28.74%
25,858.00
Current Assets
6,544.00
-19.20%
8,099.00
-21.56%
10,325.00
-23.13%
13,431.00
Cash Cash Equivalents And Short Term Investments
5,799.00
-17.45%
7,025.00
-18.35%
8,604.00
-13.11%
9,902.00
Cash And Cash Equivalents
2,595.00
+34.67%
1,927.00
-33.71%
2,907.00
-9.30%
3,205.00
Other Short Term Investments
3,204.00
-37.15%
5,098.00
-10.51%
5,697.00
-14.93%
6,697.00
Receivables
284.00
-52.03%
592.00
-45.24%
1,081.00
-35.85%
1,685.00
Accounts Receivable
184.00
-48.60%
358.00
-59.87%
892.00
-35.60%
1,385.00
Gross Accounts Receivable
368.00
-47.28%
698.00
-55.93%
1,584.00
+14.37%
1,385.00
Allowance For Doubtful Accounts Receivable
-184.00
+45.88%
-340.00
+50.87%
-692.00
0.00
Other Receivables
13.00
-77.59%
58.00
-4.92%
61.00
+15.09%
53.00
Taxes Receivable
45.00
-61.54%
117.00
+69.57%
69.00
-54.00%
150.00
Accrued Interest Receivable
42.00
-28.81%
59.00
+0.00%
59.00
-3.28%
61.00
Inventory
153.00
+30.77%
117.00
-42.08%
202.00
-78.71%
949.00
Raw Materials
91.00
+44.44%
63.00
-61.35%
163.00
-71.65%
575.00
Work In Process
29.00
+11.54%
26.00
+73.33%
15.00
-92.68%
205.00
Finished Goods
33.00
+17.86%
28.00
+16.67%
24.00
-85.80%
169.00
Prepaid Assets
263.00
-14.33%
307.00
-12.29%
350.00
-58.87%
851.00
Hedging Assets Current
—
—
—
—
Other Current Assets
45.00
-22.41%
58.00
-34.09%
88.00
+100.00%
44.00
Total Non Current Assets
5,794.00
-4.12%
6,043.00
-25.40%
8,101.00
-34.81%
12,427.00
Net PPE
2,853.00
-3.45%
2,955.00
+11.17%
2,658.00
+24.26%
2,139.00
Gross PPE
3,590.00
+3.10%
3,482.00
+12.65%
3,091.00
+10.51%
2,797.00
Accumulated Depreciation
-737.00
-39.85%
-527.00
-21.71%
-433.00
+34.19%
-658.00
Properties
0.00
0.00
0.00
0.00
Land And Improvements
78.00
+32.20%
59.00
+168.18%
22.00
+100.00%
11.00
Buildings And Improvements
1,183.00
+59.22%
743.00
0.00
—
Machinery Furniture Equipment
235.00
+29.83%
181.00
+81.00%
100.00
+69.49%
59.00
Construction In Progress
298.00
-71.81%
1,057.00
+22.91%
860.00
+206.05%
281.00
Other Properties
1,393.00
+12.79%
1,235.00
-22.18%
1,587.00
-20.09%
1,986.00
Leases
403.00
+94.69%
207.00
-60.34%
522.00
+13.48%
460.00
Goodwill And Other Intangible Assets
97.00
+5.43%
92.00
-4.17%
96.00
0.00
Goodwill
52.00
+0.00%
52.00
+0.00%
52.00
0.00
Other Intangible Assets
45.00
+12.50%
40.00
-9.09%
44.00
—
Investments And Advances
2,342.00
-6.62%
2,508.00
-47.12%
4,743.00
-43.27%
8,360.00
Long Term Equity Investment
6.00
-57.14%
14.00
-78.79%
66.00
+57.14%
42.00
Non Current Accounts Receivable
161.00
+65.98%
97.00
—
—
Non Current Deferred Assets
81.00
+0.00%
81.00
+0.00%
81.00
-91.75%
982.00
Non Current Deferred Taxes Assets
81.00
+0.00%
81.00
+0.00%
81.00
-91.75%
982.00
Non Current Prepaid Assets
100.00
-28.06%
139.00
-59.36%
342.00
0.00
Other Non Current Assets
160.00
-6.43%
171.00
-5.52%
181.00
-80.87%
946.00
Total Liabilities Net Minority Interest
3,688.00
+13.79%
3,241.00
-29.11%
4,572.00
-32.12%
6,735.00
Current Liabilities
1,987.00
-9.93%
2,206.00
-26.83%
3,015.00
-38.76%
4,923.00
Payables And Accrued Expenses
774.00
-32.70%
1,150.00
-27.22%
1,580.00
-35.40%
2,446.00
Payables
317.00
-21.73%
405.00
-30.53%
583.00
+8.97%
535.00
Accounts Payable
317.00
-21.73%
405.00
-22.12%
520.00
+6.78%
487.00
Current Accrued Expenses
457.00
-38.66%
745.00
-25.28%
997.00
-47.83%
1,911.00
Pensionand Other Post Retirement Benefit Plans Current
420.00
+34.62%
312.00
+27.35%
245.00
+28.95%
190.00
Total Tax Payable
—
3.00
-95.24%
63.00
+31.25%
48.00
Income Tax Payable
—
3.00
-95.24%
63.00
+31.25%
48.00
Current Debt And Capital Lease Obligation
42.00
+13.51%
37.00
+48.00%
25.00
-87.24%
196.00
Current Capital Lease Obligation
42.00
+13.51%
37.00
+48.00%
25.00
-87.24%
196.00
Current Deferred Liabilities
99.00
-35.29%
153.00
-73.06%
568.00
-72.13%
2,038.00
Current Deferred Revenue
99.00
-35.29%
153.00
-73.06%
568.00
-72.13%
2,038.00
Other Current Liabilities
143.00
-22.28%
184.00
+348.78%
41.00
-22.64%
53.00
Total Non Current Liabilities Net Minority Interest
1,701.00
+64.35%
1,035.00
-33.53%
1,557.00
-14.07%
1,812.00
Long Term Debt And Capital Lease Obligation
1,263.00
+77.89%
710.00
-41.71%
1,218.00
+21.31%
1,004.00
Long Term Debt
590.00
—
—
—
Long Term Capital Lease Obligation
673.00
-5.21%
710.00
-41.71%
1,218.00
+21.31%
1,004.00
Tradeand Other Payables Non Current
249.00
+7.79%
231.00
-1.70%
235.00
—
Non Current Deferred Liabilities
153.00
+163.79%
58.00
-30.12%
83.00
-87.67%
673.00
Non Current Deferred Revenue
153.00
+163.79%
58.00
-30.12%
83.00
-87.67%
673.00
Other Non Current Liabilities
36.00
+0.00%
36.00
+71.43%
21.00
-84.44%
135.00
Stockholders Equity
8,650.00
-20.65%
10,901.00
-21.32%
13,854.00
-27.55%
19,123.00
Common Stock Equity
8,650.00
-20.65%
10,901.00
-21.32%
13,854.00
-27.55%
19,123.00
Capital Stock
0.00
0.00
0.00
0.00
Common Stock
0.00
0.00
0.00
0.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
394.00
+2.07%
386.00
+1.05%
382.00
-0.78%
385.00
Ordinary Shares Number
394.00
+2.07%
386.00
+1.05%
382.00
-0.78%
385.00
Additional Paid In Capital
1,382.00
+59.58%
866.00
+133.42%
371.00
-68.37%
1,173.00
Retained Earnings
7,223.00
-28.09%
10,045.00
-26.17%
13,606.00
-25.73%
18,320.00
Gains Losses Not Affecting Retained Earnings
45.00
+550.00%
-10.00
+91.87%
-123.00
+66.76%
-370.00
Other Equity Adjustments
45.00
+550.00%
-10.00
+91.87%
-123.00
+66.76%
-370.00
Total Equity Gross Minority Interest
8,650.00
-20.65%
10,901.00
-21.32%
13,854.00
-27.55%
19,123.00
Total Capitalization
9,240.00
-15.24%
10,901.00
-21.32%
13,854.00
-27.55%
19,123.00
Working Capital
4,557.00
-22.67%
5,893.00
-19.38%
7,310.00
-14.08%
8,508.00
Invested Capital
9,240.00
-15.24%
10,901.00
-21.32%
13,854.00
-27.55%
19,123.00
Total Debt
1,305.00
+74.70%
747.00
-39.90%
1,243.00
+3.58%
1,200.00
Capital Lease Obligations
715.00
-4.28%
747.00
-39.90%
1,243.00
+3.58%
1,200.00
Net Tangible Assets
8,553.00
-20.87%
10,809.00
-21.43%
13,758.00
-28.06%
19,123.00
Tangible Book Value
8,553.00
-20.87%
10,809.00
-21.43%
13,758.00
-28.06%
19,123.00
Available For Sale Securities
2,336.00
-6.34%
2,494.00
-46.68%
4,677.00
-43.77%
8,318.00
Current Provisions
509.00
+37.57%
370.00
-33.45%
556.00
—
Investmentin Financial Assets
2,336.00
-6.34%
2,494.00
-46.68%
4,677.00
-43.77%
8,318.00
Notes Receivable
—
—
0.00
-100.00%
36.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-1,873.00
+37.65%
-3,004.00
+3.66%
-3,118.00
-162.60%
4,981.00
Cash Flow From Continuing Operating Activities
-1,873.00
+37.65%
-3,004.00
+3.66%
-3,118.00
-162.60%
4,981.00
Net Income From Continuing Operations
-2,822.00
+20.75%
-3,561.00
+24.46%
-4,714.00
-156.37%
8,362.00
Depreciation Amortization Depletion
215.00
+13.76%
189.00
-69.57%
621.00
+78.45%
348.00
Depreciation And Amortization
215.00
+13.76%
189.00
-69.57%
621.00
+78.45%
348.00
Other Non Cash Items
77.00
+28.33%
60.00
+757.14%
7.00
-75.00%
28.00
Stock Based Compensation
483.00
+12.59%
429.00
+40.66%
305.00
+34.96%
226.00
Deferred Tax
—
—
828.00
+248.12%
-559.00
Deferred Income Tax
—
—
828.00
+248.12%
-559.00
Operating Gains Losses
8.00
-84.62%
52.00
+48.57%
35.00
—
Change In Working Capital
233.00
+398.72%
-78.00
-111.32%
689.00
+117.16%
-4,014.00
Change In Receivables
156.00
-70.79%
534.00
+8.32%
493.00
-72.46%
1,790.00
Changes In Account Receivables
156.00
-70.79%
534.00
+8.32%
493.00
-72.46%
1,790.00
Change In Inventory
-34.00
-140.96%
83.00
-88.89%
747.00
+51.83%
492.00
Change In Prepaid Assets
153.00
+5.52%
145.00
-91.95%
1,802.00
+179.81%
-2,258.00
Change In Payables And Accrued Expense
-94.00
+79.30%
-454.00
-38.84%
-327.00
-138.38%
852.00
Change In Accrued Expense
-2.00
+99.48%
-385.00
-13.24%
-340.00
-155.56%
612.00
Change In Payable
-92.00
-33.33%
-69.00
-630.77%
13.00
-94.58%
240.00
Change In Account Payable
-92.00
-33.33%
-69.00
-630.77%
13.00
-94.58%
240.00
Change In Other Working Capital
41.00
+109.34%
-439.00
+78.69%
-2,060.00
+50.45%
-4,157.00
Change In Other Current Assets
38.00
+171.70%
-53.00
+91.24%
-605.00
-2980.95%
21.00
Change In Other Current Liabilities
-27.00
-125.47%
106.00
-83.41%
639.00
+184.75%
-754.00
Investing Cash Flow
1,946.00
-0.15%
1,949.00
-53.66%
4,206.00
+181.26%
-5,176.00
Cash Flow From Continuing Investing Activities
1,946.00
-0.15%
1,949.00
-53.66%
4,206.00
+181.26%
-5,176.00
Net PPE Purchase And Sale
-192.00
+81.73%
-1,051.00
-48.66%
-707.00
-76.75%
-400.00
Purchase Of PPE
-192.00
+81.73%
-1,051.00
-48.66%
-707.00
-76.75%
-400.00
Capital Expenditure
-202.00
+80.78%
-1,051.00
-48.66%
-707.00
-76.75%
-400.00
Net Investment Purchase And Sale
2,148.00
-28.40%
3,000.00
-39.98%
4,998.00
+205.53%
-4,736.00
Purchase Of Investment
-5,768.00
+11.66%
-6,529.00
-72.59%
-3,783.00
+66.92%
-11,435.00
Sale Of Investment
7,916.00
-16.93%
9,529.00
+8.52%
8,781.00
+31.08%
6,699.00
Net Business Purchase And Sale
0.00
0.00
+100.00%
-85.00
0.00
Purchase Of Business
0.00
0.00
+100.00%
-85.00
0.00
Net Intangibles Purchase And Sale
-10.00
0.00
0.00
—
Purchase Of Intangibles
-10.00
0.00
0.00
—
Net Other Investing Changes
—
—
-23.00
+42.50%
-40.00
Financing Cash Flow
593.00
+958.93%
56.00
+104.07%
-1,377.00
+60.06%
-3,448.00
Cash Flow From Continuing Financing Activities
593.00
+958.93%
56.00
+104.07%
-1,377.00
+60.06%
-3,448.00
Net Issuance Payments Of Debt
560.00
+5700.00%
-10.00
+96.30%
-270.00
-46.74%
-184.00
Issuance Of Debt
600.00
0.00
0.00
—
Repayment Of Debt
-22.00
0.00
0.00
—
Long Term Debt Issuance
600.00
0.00
0.00
—
Long Term Debt Payments
-22.00
0.00
0.00
—
Net Long Term Debt Issuance
560.00
+5700.00%
-10.00
+96.30%
-270.00
-46.74%
-184.00
Net Common Stock Issuance
35.00
-46.97%
66.00
+43.48%
46.00
+101.41%
-3,264.00
Common Stock Payments
—
0.00
+100.00%
-1,153.00
+65.36%
-3,329.00
Repurchase Of Capital Stock
—
0.00
+100.00%
-1,153.00
+65.36%
-3,329.00
Proceeds From Stock Option Exercised
—
—
46.00
-29.23%
65.00
Net Other Financing Charges
-2.00
—
-1,153.00
—
Changes In Cash
666.00
+166.67%
-999.00
-245.67%
-289.00
+92.07%
-3,643.00
Effect Of Exchange Rate Changes
2.00
0.00
0.00
—
Beginning Cash Position
1,929.00
-34.12%
2,928.00
-8.98%
3,217.00
-53.10%
6,860.00
End Cash Position
2,597.00
+34.63%
1,929.00
-34.12%
2,928.00
-8.98%
3,217.00
Free Cash Flow
-2,075.00
+48.83%
-4,055.00
-6.01%
-3,825.00
-183.50%
4,581.00
Interest Paid Supplemental Data
10.00
-58.33%
24.00
-38.46%
39.00
+56.00%
25.00
Income Tax Paid Supplemental Data
26.00
-86.80%
197.00
—
2,729.00
Amortization Of Securities
-67.00
+29.47%
-95.00
-55.74%
-61.00
-296.77%
31.00
Change In Income Tax Payable
—
—
15.00
+101.81%
-828.00
Change In Tax Payable
—
—
15.00
+101.81%
-828.00
Common Stock Issuance
35.00
-46.97%
66.00
+43.48%
46.00
-29.23%
65.00
Earnings Losses From Equity Investments
8.00
-84.62%
52.00
+48.57%
35.00
0.00
Issuance Of Capital Stock
35.00
-46.97%
66.00
+43.48%
46.00
-29.23%
65.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category